Skip to main content
Menu
US

HTRF Human and Mouse Phospho-Tau (Ser356) Detection Kit, 500 Assay Points

This HTRF kit enables the cell-based detection of phosphorylated TAU at Serine 356, as a marker of neurodegenerative diseases.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Feature Specification
Application Cell Signaling
Sample Volume 16 µL

This HTRF kit enables the cell-based detection of phosphorylated TAU at Serine 356, as a marker of neurodegenerative diseases.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Product Variants
Unit Size: 500 Assay Points
Part #:
64TS356PEG
List Price
USD 2,147.00
Unit Size: 10,000 Assay Points
Part #:
64TS356PEH
List Price
USD 12,490.00

Overview

The HTRF Phospho-TAU (Ser356) cell-based assay kit is ideal for quantifying endogenous phospho-TAU phosphorylated on Serine 356. TAU exists in different states in both Alzheimer’s (AD) and Parkinson’s (PD) Diseases.

TAU hyperphosphorylation is also a marker for multiple neurodegenerative diseases and CNS disorders.

Specifications

Application
Cell Signaling
Brand
HTRF
Detection Modality
HTRF
Lysis Buffer Compatibility
Lysis Buffer 1
Lysis Buffer 3
Lysis Buffer 4
Lysis Buffer 5
Molecular Modification
Phosphorylation
Product Group
Kit
Sample Volume
16 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Phosphoproteins
Target Species
Human
Mouse
Technology
TR-FRET
Therapeutic Area
Neuroscience
Unit Size
500 Assay Points

Video gallery

How it works

Phospho-TAU (Ser356) assay principle

The Phospho-TAU (Ser356) assay measures TAU when phosphorylated at Ser356. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis, or transfer.

The Phospho-TAU (Ser356) assay uses 2 labeled antibodies: one with a donor fluorophore, and the other with an acceptor. The first antibody was selected for its specific binding to the phosphorylated motif on the protein, and the second for its ability to recognize the protein independent from its phosphorylation state. Protein phosphorylation enables an immune-complex formation involving both labeled antibodies and which brings the donor fluorophore into close proximity to the acceptor, thereby generating a FRET signal. Its intensity is directly proportional to the concentration of phosphorylated protein present in the sample, and provides a means of assessing the protein’s phosphorylation state under a no-wash assay format.

Phospho tau s356
Phospho-TAU (Ser356) 2-plate assay protocol

The 2 plate protocol involves culturing cells in a 96-well plate before lysis, then transferring lysates to a 384-well low volume detection plate before the addition of Phospho-TAU (Ser356) HTRF detection reagents.

This protocol enables the cells' viability and confluence to be monitored.

Phospho tau s356 2 plate assay protocol
Phospho-TAU (Ser356) 1-plate assay protocol

Detection of Phosphorylated TAU (Ser356) with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required.

This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.

Phospho tau s356 plate assay protocol

 

Assay validation

Assessment of Tau S356 phosphorylation after BIO-induced GSK3 inhibition in human SH-SHY5Y cell line

Human SH-SY5Y cells were plated at 100,000 cells/well in a 96-well plate. After 24 h incubation at 37 °C, 5% CO2, the cells were treated with increasing concentrations of GSK3α/β inhibitor BIO (6-bromoindirubin-3-oxime) for 1 h, followed by 2 h Okadaic acid (100nM) and 10 min Calyculin A (100nM) treatments. Then the medium was removed and 50 µL of supplemented lysis buffer 1X were added. After 30min lysis at RT under gentle shaking, 16 µL of lysate were transferred into a 384-well low volume white microplate and 4 µL of the HTRF phospho-Tau (Ser356) or total Tau detection reagents were added. The HTRF signal was recorded after an overnight incubation.

 

BIO-induced GSK3α/β inhibition leads to a complete inhibition of Tau phosphorylation on Serine 356, whereas the Tau expression level remains stable under the same experimental conditions.

Assay validation tau phospho s356
Assessment of Tau S356 phosphorylation after BIO-induced GSK3 inhibition in mouse Neuro2a cell line

Mouse Neuro2a cells were plated at 100,000 cells/well in a 96-well plate. After 24 h incubation at 37 °C, 5% CO2, the cells were treated with increasing concentrations of GSK3α/β inhibitor BIO (6-bromoindirubin-3-oxime) for 1 h, followed by 2 h Okadaic acid (100nM) and 10 min Calyculin A (100nM) treatments. Then the medium was removed and 50 µL of supplemented lysis buffer 1X were added. After 30min lysis at RT under gentle shaking, 16 µL of lysate were transferred into a 384-well low volume white microplate and 4 µL of the HTRF phospho-Tau (Ser356) or total Tau detection reagents were added. The HTRF signal was recorded after an overnight incubation.

 

As in SH-SY5Y cells, BIO-mediated GSK3α/β inhibition leads to a complete inhibition of Tau phosphorylation on Serine 356. Note that the total Tau assay is human specific and does not cross react with mouse models.

Assay validation tau phospho s356
HTRF phospho-Tau (Ser356) assay compared to Western Blot

Human Neuroblastoma SH-SY5Y cells were seeded in a T175 flask in complete culture medium and incubated for 2 days at 37°C, 5% CO2. Then the cells were treated with Okadaic acid (100 nM) for 2 h and Calyculin A (100 nM) for 10 min. Following these treatments, the cells were lysed with 3 mL of supplemented lysis buffer#1 for 30min at RT under gentle shaking. Soluble supernatants were collected after a 10 minute centrifugation.

Serial dilutions of the cell lysate were performed in the supplemented lysis buffer and 16 µL of each dilution were transferred into a 384-well low volume white microplate before the addition of 4 µL of the HTRF HTRF phospho-Tau (Ser356) detection reagents. Equal amounts of lysates were used for a side by side comparison between Western Blot and HTRF.

 

This result demonstrates that the phospho-Tau (Ser356) assay is 4-fold more sensitive than the Western Blot, at least under these experimental conditions.

Phospho s356

 

Simplified pathway

Role of the protein Tau in Alzheimer's disease pathway

Tau has a prominent role in the pathogenesis of Alzheimer's Disease. It becomes hyperphosphorylated and aggregates, forming filaments, which can further condense into neurofibrillary tangles. Tau aggregates may propagate pathology by spreading from cell to cell in a prion-like manner. Drugs modulating Tau hyperphosphorylation and reducing Tau aggregation are viable therapeutic approaches.

 

The physiological role of Tau protein is to promote the assembly and stability of microtubules. Six isoforms of Tau have been described, ranging from 352 to 441 residues coming from exons 2, 3, and 10, that are alternatively spliced. The longest isoform of Tau (Tau-441) contains 85 putative phosphorylation sites, half of which have been confirmed experimentally.

 

Phospho s356 kit

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Guide Icon
Guide
Download your guide about neurodegenerative diseases

Emerging pathways to neuroinflammation and neurodegeneration

Neurodegenerative diseases, such as amyotrophic lateral sclerosis...

Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Scroll Icon